Shares of Oxford Industries sank after hours Wednesday after the maker of Tommy Bahama and Lilly Pulitzer clothing cut its full-year forecast — citing the impact of hurricanes Milton and Helene on the ...
Telehealth firm Ro has partnered with Eli Lilly And Co (NYSE:LLY) to enhance patient access to Zepbound (tirzepatide) single-dose vials for obesity treatment. Through LillyDirect, Ro will provide ...
Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen receptor degrader (SERD), in patients with ...
Oxford Industries expects full-year earnings in the range of $6.50 to $6.70 per share, with revenue ranging from $1.5 billion to $1.52 billion. This story was generated by Automated Insights ( ...
It is tailored to patients being treated with Lilly's oncology drugs – which include blockbuster CDK 4/ 6 inhibitor Verzenio (abemaciclib) for hormone receptor-positive, HER2-negative breast ...
Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...